Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Genpact Ltd’s stock clocked out at $43.25%, Down $-0.67% from its previous closing price of $43.54. In other words, the price has decreased by -$0.67 from its previous closing price. On the day, 1.89 million shares were traded. G stock price reached its highest trading level at $44.09 during the session, while it also had its lowest trading level at $43.18.
Ratios:
To gain a deeper understanding of G’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.40 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.37. For the most recent quarter (mrq), Quick Ratio is recorded 1.53 and its Current Ratio is at 1.53. In the meantime, Its Debt-to-Equity ratio is 0.59 whereas as Long-Term Debt/Eq ratio is at 0.39.
On February 07, 2025, TD Cowen Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $45 to $60.
Jefferies Upgraded its Hold to Buy on January 21, 2025, whereas the target price for the stock was revised from $44 to $55.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 13 ’25 when Gangestad Nicholas C bought 2,000 shares for $43.97 per share. The transaction valued at 87,940 led to the insider holds 2,000 shares of the business.
Kalra Balkrishan sold 13,600 shares of G for $664,904 on Mar 13 ’25. The President and CEO now owns 310,246 shares after completing the transaction at $48.89 per share. On Mar 13 ’25, another insider, BALKRISHAN KALRA, who serves as the Officer of the company, bought 13,600 shares for $48.89 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, G now has a Market Capitalization of 7536961024 and an Enterprise Value of 8384626688. As of this moment, Genpact’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.35, and their Forward P/E ratio for the next fiscal year is 11.13. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.50. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.54 while its Price-to-Book (P/B) ratio in mrq is 2.91. Its current Enterprise Value per Revenue stands at 1.701 whereas that against EBITDA is 10.235.
Stock Price History:
The Beta on a monthly basis for G is 0.93, which has changed by 0.15149093 over the last 52 weeks, in comparison to a change of 0.17279088 over the same period for the S&P500. Over the past 52 weeks, G has reached a high of $56.76, while it has fallen to a 52-week low of $35.42. The 50-Day Moving Average of the stock is -1.29%, while the 200-Day Moving Average is calculated to be -5.87%.
Shares Statistics:
It appears that G traded 1.67M shares on average per day over the past three months and 2339340 shares per day over the past ten days. A total of 174.26M shares are outstanding, with a floating share count of 160.50M. Insiders hold about 8.22% of the company’s shares, while institutions hold 94.75% stake in the company. Shares short for G as of 1753920000 were 6929867 with a Short Ratio of 4.14, compared to 1751241600 on 6430241. Therefore, it implies a Short% of Shares Outstanding of 6929867 and a Short% of Float of 4.54.
Dividends & Splits
With its trailing 12-month dividend rate of 0.645, G has a forward annual dividend rate of 0.64. Against a Trailing Annual Dividend Yield of 0.014813963The stock’s 5-year Average Dividend Yield is 1.21.
Earnings Estimates
The current market rating for Genpact Ltd (G) reflects the collective analysis of 8.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.93, with high estimates of $0.94 and low estimates of $0.91.
Analysts are recommending an EPS of between $3.57 and $3.52 for the fiscal current year, implying an average EPS of $3.55. EPS for the following year is $3.88, with 10.0 analysts recommending between $3.97 and $3.82.
Revenue Estimates
In the current quarter, 8 analysts expect revenue to total $1.27B. It ranges from a high estimate of $1.27B to a low estimate of $1.26B. As of the current estimate, Genpact Ltd’s year-ago sales were $1.21BFor the next quarter, 8 analysts are estimating revenue of $1.29B. There is a high estimate of $1.3B for the next quarter, whereas the lowest estimate is $1.27B.
A total of 10 analysts have provided revenue estimates for G’s current fiscal year. The highest revenue estimate was $5.04B, while the lowest revenue estimate was $5.01B, resulting in an average revenue estimate of $5.02B. In the same quarter a year ago, actual revenue was $4.77BBased on 10 analysts’ estimates, the company’s revenue will be $5.36B in the next fiscal year. The high estimate is $5.45B and the low estimate is $5.26B.
